Breadcrumb AMCP.org Resource Center AMCP submits comments on Hawaii HB 254 concerning biosimilars Tweet this pagePost this page on FacebookPost this page on LinkedInEmail this pagePrint this page 3/18/19 AMCP submits comments on Hawaii HB 254 concerning biosimilars AMCP Comments RE - H.B. 254.pdf Tweet this pagePost this page on FacebookPost this page on LinkedInEmail this pagePrint this page